🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to collect data from patients by social media ...
Status
Completed
Location
Lymphoma House086
Start Date
2017-03-08
Trial ID
NCT03079544
Treatments Being Tested
This randomized phase III trial studies how well imatinib mesylate works in...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2017-08-08
Trial ID
NCT03007147
Treatments Being Tested
Objectives: A. Primary objective: 1 To assess the feasibility and the eff...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2006-09-12
Trial ID
NCT00866749
The vast majority of patients with ALL will die of the disease, and no stan...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2016-01-01
Trial ID
NCT03318419
Treatments Being Tested
This is a randomized, open-label, prospective, multicenter phase III superi...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center,
Start Date
2026-08-11
Trial ID
NCT07678229
Purpose :To compare the efficacy and and safety of the P-Gemox chemotherapy...
Status
Terminated
Location
Sun Yat-sen University Cancer Center
Start Date
2015-05
Trial ID
NCT02359162
In the proposed study, escalating doses of inotuzumab ozogamicin will be ad...
Status
Unknown
Location
Vanderbilt-Ingram Cancer Center
Start Date
2022-07-22
Trial ID
NCT03962465
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Completed
Location
Krankenanstalten Gilead gCmbH Neurochirurgische Klinik
Start Date
2010-10
Trial ID
NCT01228331
Ph-like ALL is a recently recognized high-risk subgroup and the optimal the...
Status
Unknown
Location
Department of Hematology, Nanfang Hospital
Start Date
2016-02-14
Trial ID
NCT03564470
The first Part: recruiting untreated ENKL patients with extensive stage I o...
Status
Unknown
Location
Cancer Institute/Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
Start Date
2015-09
Trial ID
NCT02560441